196
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Absorption of daunorubicin and etoposide drugs by hydroxylated and carboxylated carbon nanotube for drug delivery: theoretical and experimental studies

, &
Pages 10057-10064 | Received 21 Mar 2021, Accepted 30 May 2021, Published online: 24 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ajit Kumar Rai & Neeraj Kumar Satija. (2023) A comparative analysis of daunorubicin and its metabolite daunorubicinol interaction with apoptotic and drug resistance proteins using in silico approach. Journal of Biomolecular Structure and Dynamics 41:20, pages 10737-10749.
Read now

Articles from other publishers (4)

Hugh Mohan, Andrew Fagan & Silvia Giordani. (2023) Carbon Nanomaterials (CNMs) in Cancer Therapy: A Database of CNM-Based Nanocarrier Systems. Pharmaceutics 15:5, pages 1545.
Crossref
Xueli Xu, Ao Liu, Shuangqing Liu, Yanling Ma, Xinyu Zhang, Meng Zhang, Jinhua Zhao, Shuo Sun & Xiao Sun. (2023) Application of molecular dynamics simulation in self-assembled cancer nanomedicine. Biomaterials Research 27:1.
Crossref
Debabrata Ghosh Dastidar, Dipanjan Ghosh & Amlan Das. (2022) Recent developments in nanocarriers for cancer chemotherapy. OpenNano 8, pages 100080.
Crossref
Xiao-Hui Yin, Yan-Ming Xu & Andy T. Y. Lau. (2022) Nanoparticles: Excellent Materials Yet Dangerous When They Become Airborne. Toxics 10:2, pages 50.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.